title: Sentinel node scintigraphy in breast cancer using a dual tracer technique.
abstract: OBJECTIVE
  In order to depict the anatomy and improve the localization, sentinel node scintigraphy in breast cancer was combined with intravenous administration of pertechnetate. As this may reduce the detectability of weak 'hot spots', the number of lymph nodes detected at scintigraphy and at surgery in one group of patients was compared with that obtained in another group that had not received pertechnetate.
  
  
  METHODS
  The number of 'hot spots' at frontal and lateral views in 47 female patients at scintigraphy performed 2-3 h after subcutaneous injection of radiocolloid together with 25 MBq pertechnetate i.v. was compared in retrospect with that of 41 female patients who had not received pertechnetate. The number of lymph nodes detected at surgery using a hand-held gamma probe together with blue dye in the two groups was also compared. The washout kinetics of pertechnetate was studied in 10 patients.
  
  
  RESULTS
  There was no difference in the number of detected lymph nodes at any comparison. The kinetics study revealed a decreasing activity with time after correction for physical decay.
  
  
  CONCLUSIONS
  Administration of a 25 MBq pertechnetate i.v. in order to improve the anatomical localization at sentinel node scintigraphy in breast cancer does not reduce the detectability of radioactive lymph nodes.
authors.affiliation: Department of Radiology, Huddinge University Hospital, Huddinge, Sweden. brigitte.wilczek@hs.se
authors.forename: Brigitte
authors.initials: B
authors.lastname: Wilczek
authors.forename: Kerstia
authors.initials: K
authors.lastname: Sandelin
authors.forename: Staffan
authors.initials: S
authors.lastname: Eriksson
authors.forename: Stig A
authors.initials: SA
authors.lastname: Larsson
authors.forename: Hans
authors.initials: H
authors.lastname: Jacobsson
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000601:surgery; D004396:Coloring Agents; D005260:Female; D015902:Gamma Cameras; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging*; D008875:Middle Aged; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000737:chemistry / Q000493:pharmacokinetics; D012189:Retrospective Studies; D021701:Sentinel Lymph Node Biopsy; D013670:Sodium Pertechnetate Tc 99m / Q000737:chemistry / Q000493:pharmacokinetics; D013668:Technetium Tc 99m Aggregated Albumin / Q000737:chemistry / Q000493:pharmacokinetics
chemical_list: D004396:Coloring Agents; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; D013670:Sodium Pertechnetate Tc 99m